First Citizens Bank & Trust’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-3,501
| Closed | -$231K | – | 464 |
|
|
2017
Q1 | $231K | Sell |
3,501
-189
| -5% | -$12.5K | 0.03% | 430 |
|
|
2016
Q4 | $234K | Sell |
3,690
-1,661
| -31% | -$105K | 0.03% | 412 |
|
|
2016
Q3 | $341K | Sell |
5,351
-1,816
| -25% | -$116K | 0.03% | 368 |
|
|
2016
Q2 | $533K | Sell |
7,167
-6,103
| -46% | -$454K | 0.05% | 259 |
|
|
2016
Q1 | $886K | Sell |
13,270
-9,812
| -43% | -$655K | 0.07% | 164 |
|
|
2015
Q4 | $1.56M | Sell |
23,082
-24,894
| -52% | -$1.68M | 0.11% | 130 |
|
|
2015
Q3 | $2.56M | Buy |
+47,976
| New | +$2.56M | 0.19% | 107 |
|